Safety and Effectiveness of Vibegron in Japanese Patients With Overactive Bladder: A Japanese Postmarketing Survey
This survey found no major concerns regarding the safety and effectiveness of vibegron in Japanese OAB patients, except for urinary retention-related AEs. Vibegron is considered to represent a useful drug for treating OAB symptoms in a real-world clinical setting.
Authors
- Masakazu Yamasaki
- Kazunori Abe (ORCID: https://orcid.org/0000-0001-9781-2416)
- Hiromitsu Yagi
- Shoko Yoshimura
Institutions
- Kyorin University (JP)
- Kissei Pharmaceutical (Japan) (JP)
Publication Details
- Journal
- LUTS Lower Urinary Tract Symptoms
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1111/luts.12535
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Kissei
- Kyorin Pharmaceutical